FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1069211000001101: Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22000101000001118 Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
43624101000001116 Co-amoxiclav 250mg/125mg dispersible tablets sugar free 21 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Is pack of Amoxicillin + clavulanate potassium 250mg/125mg s/f dispersible tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has VMP Co-amoxiclav 250mg/125mg dispersible tablets sugar free true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has VMP Product containing only amoxicillin and clavulanic acid in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has VMP Amoxicillin + clavulanate potassium 250mg/125mg s/f dispersible tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Has VMP Co-amoxiclav 250mg/125mg dispersible tablets sugar free false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Is a True Co-amoxiclav 250mg/125mg dispersible tablets 21 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start